Ono Pharmaceutical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3197600004
JPY
2,387.50
55.5 (2.38%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
1,39,900.00
1,29,600.00
1,27,536.00
1,12,309.00
1,34,223.00
1,22,664.00
1,17,675.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,39,900.00
1,29,600.00
1,27,536.00
1,12,309.00
1,34,223.00
1,22,664.00
1,17,675.00
Raw Material Cost
36,681.00
34,963.00
37,013.00
45,237.00
45,836.00
27,206.00
29,671.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
408.00
1,226.00
773.00
2,459.00
0.00
3,447.00
75.00
Selling and Distribution Expenses
31,729.00
30,085.00
31,086.00
31,932.00
35,315.00
30,538.00
27,886.00
Other Expenses
3,312.50
3,354.30
3,547.90
4,033.50
3,826.90
3,649.90
2,878.20
Total Expenditure (Excl Depreciation)
1,01,943.00
99,817.00
1,04,351.00
1,19,963.00
1,19,420.00
97,690.00
86,414.00
Operating Profit (PBDIT) excl Other Income
37957
29783
23185
-7654
14803
24974
31261
Other Income
-347.00
968.00
238.00
-2,717.00
2,598.00
-203.00
2,123.00
Operating Profit (PBDIT)
47,204.00
40,064.00
32,661.00
-1,643.00
26,571.00
29,388.00
37,763.00
Interest
408.00
1,226.00
773.00
2,459.00
0.00
3,447.00
75.00
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
1,03,219.00
94,637.00
90,523.00
67,072.00
88,387.00
95,458.00
88,004.00
Depreciation
9,594.00
9,313.00
9,238.00
8,728.00
9,170.00
4,617.00
4,379.00
Profit Before Tax
37,202.00
29,525.00
22,650.00
-12,831.00
17,399.00
21,325.00
33,310.00
Tax
8,314.00
7,174.00
5,019.00
-6,341.00
2,514.00
4,516.00
8,474.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
28,861.00
22,499.00
17,589.00
-6,545.00
14,939.00
16,860.00
24,793.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
28,861.00
22,499.00
17,589.00
-6,545.00
14,939.00
16,860.00
24,793.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
28.00
-149.00
42.00
178.00
-53.00
-48.00
42.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
28,889.00
22,350.00
17,631.00
-6,367.00
14,886.00
16,812.00
24,835.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
8,39,670.00
8,06,350.00
7,72,638.00
7,82,451.00
8,15,918.00
7,82,463.00
8,10,731.00
Earnings per share (EPS)
61.42
47.7
37.58
-13.93
31.81
35.86
52.75
Diluted Earnings per share
61.42
47.7
37.58
-13.93
31.81
35.86
52.75
Operating Profit Margin (Excl OI)
27.13%
22.98%
18.18%
-6.82%
11.03%
20.36%
26.57%
Gross Profit Margin
33.45%
29.97%
25.0%
-3.65%
19.79%
21.15%
32.03%
PAT Margin
20.63%
17.36%
13.79%
-5.83%
11.13%
13.74%
21.07%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2025 is 4.23% vs 2.31% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Dec 2025 is 94.07% vs -58.75% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is 98.35% vs -53.91% in Dec 2024

stock-summary

Interest

YoY Growth in quarter ended Dec 2025 is 0.00% vs -100.00% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024

Compare Quarterly Results Of Ono Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
1,39,900.00
1,47,719.00
-7,819.00
-5.29%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,39,900.00
1,47,719.00
-7,819.00
-5.29%
Raw Material Cost
36,681.00
25,652.00
11,029.00
42.99%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
408.00
1,611.00
-1,203.00
-74.67%
Selling and Distribution Expenses
31,729.00
35,484.00
-3,755.00
-10.58%
Other Expenses
3,312.50
2,825.60
486.90
17.23%
Total Expenditure (Excl Depreciation)
1,01,943.00
91,003.00
10,940.00
12.02%
Operating Profit (PBDIT) excl Other Income
37,957.00
56,716.00
-18,759.00
-33.08%
Other Income
-347.00
37,782.00
-38,129.00
-100.92%
Operating Profit (PBDIT)
47,204.00
1,00,533.00
-53,329.00
-53.05%
Interest
408.00
1,611.00
-1,203.00
-74.67%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
1,03,219.00
1,22,067.00
-18,848.00
-15.44%
Depreciation
9,594.00
6,035.00
3,559.00
58.97%
Profit Before Tax
37,202.00
92,886.00
-55,684.00
-59.95%
Tax
8,314.00
18,206.00
-9,892.00
-54.33%
Provisions and contingencies
0
0
0.00
Profit After Tax
28,861.00
74,683.00
-45,822.00
-61.36%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
28,861.00
74,683.00
-45,822.00
-61.36%
Share in Profit of Associates
0
0
0.00
Minority Interest
28.00
-3.00
31.00
1,033.33%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
28,889.00
74,680.00
-45,791.00
-61.32%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
8,39,670.00
15,14,162.00
-6,74,492.00
-44.55%
Earnings per share (EPS)
61.42
87.75
-26.33
-30.01%
Diluted Earnings per share
61.42
87.75
-26.33
-30.01%
Operating Profit Margin (Excl OI)
27.13%
38.39%
0.00
-11.26%
Gross Profit Margin
33.45%
66.97%
0.00
-33.52%
PAT Margin
20.63%
50.56%
0.00
-29.93%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 13,990.00 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 7.95% vs 1.62% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 4.23% vs 2.31% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 2,888.90 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 29.26% vs 26.77% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 94.07% vs -58.75% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4,755.10 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 21.63% vs 20.58% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 98.35% vs -53.91% in Dec 2024

Quarterly - Interest
Interest 40.80 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -66.72% vs 58.60% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 0.00% vs -100.00% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 27.13%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024